[HTML][HTML] Malignant Brenner tumor of the ovary: Review and case report

SM Lang, AM Mills, LA Cantrell - Gynecologic oncology reports, 2017 - Elsevier
Ovarian neoplasms are a heterogeneous group of tumors with varying incidence in the
general population. The most common are the surface epithelial tumors which include …

Imaging and differential diagnosis of ovarian cancer

M Shetty - Seminars in Ultrasound, CT and MRI, 2019 - Elsevier
Ovarian cancer is the seventh most common cancer affecting women. Despite advances in
cancer control and healthcare in general, mortality from ovarian cancer remains …

Past, present, and future of serum tumor markers in management of ovarian cancer: a guide for the radiologist

S Rao, DA Smith, E Guler, EG Kikano, MA Rajdev… - Radiographics, 2021 - pubs.rsna.org
The ability to accurately detect early ovarian cancer and subsequently monitor treatment
response is essential to improving survival for patients with ovarian malignancies. Several …

Brenner tumor of the ovary: a 10-year single institution experience and comprehensive review of the literature

F Alloush, HF Bahmad, B Lutz, R Poppiti, M Recine… - Medical …, 2023 - mdpi.com
Brenner tumors (BTs) are surface-epithelial stromal cell tumors that are categorized by the
World Health Organization as benign, borderline, and malignant. Due to the rarity of BTs, the …

[HTML][HTML] Brenner tumors of the ovary: clinical features and outcomes in a single-center cohort

D Yüksel, Ç Kılıç, C Çakır, GK Cömert… - Journal of the Turkish …, 2022 - ncbi.nlm.nih.gov
Objective: The purpose of the present study was to evaluate the clinical and pathological
features and oncological outcomes of Brenner tumors (BT). Material and Methods …

[HTML][HTML] Malignant Brenner tumor of the ovary: Case series and review of treatment strategies

Y Zhang, SA Staley, K Tucker, LH Clark - Gynecologic Oncology Reports, 2019 - Elsevier
Abstract Malignant Brenner tumor (MBTs) is a rare histological subtype of epithelial ovarian
cancer, accounting for< 0.05% of all ovarian neoplasms. As such, current evidence on the …

Update value and clinical application of MUC16 (cancer antigen 125)

Y Song, M Yuan, G Wang - Expert Opinion on Therapeutic Targets, 2023 - Taylor & Francis
Introduction The largest transmembrane mucin, mucin 16 (MUC16), contains abundant
glycosylation sites on the molecular surface, allowing it to participate in various molecular …

Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary

Y Zhu, F Meng, H Fang, Z Zhang, L Wang… - International Journal of …, 2020 - ijgc.bmj.com
Objective Neuroendocrine tumors are rare in the ovary. Definitive epidemiologic and
prognostic information for neuroendocrine carcinoma of the ovary is lacking. This …

Comparison of performance between O-RADS, IOTA simple rules risk assessment and ADNEX model in the discrimination of ovarian brenner tumors

JH Shang, T Lei, LH Wu, MF Lin, HN Xie - Archives of Gynecology and …, 2023 - Springer
Purpose To describe the clinical and sonographic features of ovarian benign Brenner tumor
(BBT) and malignant Brenner tumor (MBT), and to compare performance of four diagnostic …

[HTML][HTML] Imaging features and differential diagnosis of benign and borderline/malignant ovarian Brenner tumor

Y Jia, S Zhang, Y Ge, F Bai, Z Zhu, F Li, S Jia - Journal of Radiation …, 2024 - Elsevier
Purpose To study imaging features of ovarian Brenner tumors (BTs) and improve benign
and borderline/malignant BTs differential diagnosis. Methods This retrospective multicenter …